Scopia Capital Management L.P., 10% Owner at ACORDA THERAPEUTICS INC (ACOR), sold 193,706 shares at $16.88 ($3.2M) on 2018-12-18, disclosed to the SEC on 2018-12-19.
Open-market sale of $3.2M ACOR by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.49 | 41,853 | $690K | 21.3% |
| 2 | $16.49 | 41,853 | $690K | 21.3% |
| 3 | $16.88 | 30,000 | $506K | 15.6% |
| 4 | $16.88 | 30,000 | $506K | 15.6% |
| 5 | $16.97 | 50,000 | $849K | 26.2% |
| Total | $16.73 avg | 193,706 |
| $3.2M |
| 100% |
| Filing → |
| ITRI | SELL | 2019-05-03 | $7.4M | — | Filing → |
| ITRI | SELL | 2019-05-01 | $4.4M | — | Filing → |
| ITRI | SELL | 2019-04-22 | $1.4M | — | Filing → |